I think you are clutching at straws there, last week was the lowest volumes in months.
Usually CE approval means FDA approval but not always, we are still waiting news of the TGA approval for ADAPT......as for the CR, given the incoming revenues, I think they can last end of this year, if they start to cut those very high salary cost.
News: AHZ Admedus Says Cardiocel 3D And Vascucel Receives European Regulatory Approval, page-43
-
- There are more pages in this discussion • 525 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$18.31 |
Change
0.000(0.00%) |
Mkt cap ! $351.9M | |||
| Open | High | Low | Value | Volume |
| $18.30 | $19.00 | $18.00 | $363.4K | 19.82K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 500 | $18.13 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.50 | 1000 | 1 |
View Market Depth
| Last trade - 15.59pm 01/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |